Kaela Goldstein

Appearances

PHARMACODYNAMIC DEMONSTRATION OF IMMUNOLOGICAL TOLERANCE INDUCED BY KAN-101, A NOVEL LIVER-TARGETED THERAPY FOR CELIAC DISEASE, PERSISTS FOLLOWING DRUG CLEARANCE
Date
May 9, 2023
INTRODUCTION Interleukin-15 (IL-15) is an important cytokine involved in tissue homeostasis and inflammation, and a potent regulator of innate and adaptive immune responses…
Presenter
Joseph Murray
Speakers
Dina Wassaf
Stephanie Morgan
Stephan Kontos
Kaela Goldstein
Tom Thornley
Kristie Grebe